REalloys Inc. has committed $20.6 million to upgrade the Saskatchewan Research Council's rare earth processing facility, increasing production capacity for critical rare earth metals like Neodymium-Praseodymium, Dysprosium, and Terbium. These upgrades support REalloys' exclusive long-term supply rights to up to 80% of the expanded output, aiming to meet U.S. defense procurement requirements by 2027 without reliance on Chinese technology. The company is also progressing on a Heavy Rare Earth Metallization Facility in Ohio, with production expected by late 2027. This development is key to establishing a secure North American supply chain for heavy rare earth metals critical to defense and advanced manufacturing sectors.
California Resources Corporation has completed the first CO₂ injection at Carbon TerraVault I, California's first operational carbon capture and storage (CCS) project located in Kern County. This milestone marks a significant step toward California's...
Baker Hughes has extended and expanded its contract with Petrobras to provide integrated well construction solutions in Brazil's Santos Basin. The company will deploy advanced technologies like the AutoTrak rotary steerable system and Dynamus drill b...
Cartesian Therapeutics secured up to $150 million in non-dilutive financing from K2 HealthVentures, with an initial $50 million tranche extending its cash runway into 2028. This funding supports the advancement of multiple clinical trials for its CAR...
Rocket Lab's stock surged following strong Q1 2026 results, with revenue up 63.5% year-over-year to $200.3 million and a record backlog of $2.2 billion. The company also secured a $90 million contract from the U.S. Space Force to design and manufactu...
Lilly has agreed to acquire Curevo Vaccine, a biotech firm developing a next-generation shingles vaccine called amezosvatein, designed to improve tolerability and increase vaccination rates. The deal could pay Curevo shareholders up to $1.5 billion, ...
